The Transplant Company™ Earnings Presentation Q4 and FY 2022 Focused on improving care across the entire transplant patient journey Leslie M, Kidney Transplant Recipient Safe Harbor Statement These slides and the accompanying oral presentation contain forward-looking statements, including statements with respect to expectations regarding CareDx's upcoming milestones, vision and 2023 revenue guidance. All statements other than statements of historical fact contained in this presentation, including statements ...